key: cord-0979557-p1lcfsy5
authors: Sarici, SÜ; Candemir, G; Alpay, F
title: How reliable is clinical assessment in neonatal jaundice? Dear Sir
date: 2007-01-02
journal: Acta Paediatr
DOI: 10.1111/j.1651-2227.2004.tb03035.x
sha: 1736bb2883bd000faa3ff513cd8dd24ed56495e7
doc_id: 979557
cord_uid: p1lcfsy5

nan

Although it is stated that there were intra-and interobserver variations in estimations of bilirubin, we cannot observe these variations in each physician's assessments. Further, there seem to be no significant differences between inter-observer estimations (rvalues between 0.622 and 0.795). If the primary aim of the study was to bring alternatives to use hourspecific nomograms (2-4), then it should be strictly and statistically defined how experienced and how well trained a clinical neonatal practitioner should be, to use or to have a "Bili Eye". And, finally, how could the authors conclude that "using this method STB levels need to be measured only in significantly jaundiced babies" while they did not compare newborns with and without significant hyperbilirubinaemia? However, we wonder, and one might easily conclude that the value of "Bili Eye" remains to be determined in significantly jaundiced newborns (with STB levels of !12-13 mg/ dl), considering the absence of any significant correlation even between zone-to-zone clinical assessment and STB levels of !12 mg/dl (5). The efficacy of "Bili Eye" ACTA PAEDIATR 93 (2004) in predicting the future development of significant hyperbilirubinaemia rather than using hour-specific bilirubin nomograms may be another aspect that would further be investigated.

Dear Sir, We have read with great interest the letter of Dr S. Ü mit Sarici, Dr Göknur Candemir and Dr Faruk Alpay, and thank them for their comments. Their interest in the subject of clinical estimation of neonatal jaundice shows how important the discussion is about clinical diagnosis of jaundice. We appreciate the place that the journal Acta Paediatrica kindly provided for our manuscript and this important following discussion about the subject.

We would like to clarify the issue of intra-and interobserver variations in estimations of bilirubin. Intraobserver variations, i.e. comparison of estimations for the same physician checking the same baby at different times, and inter-observer variations, i.e. comparison of estimations of several physicians estimating the same baby at the same time, were done. These data were not presented in the manuscript, since we had only a limited number of observations because of the way this study was designed (please refer to the Methods section in our article). However, even from these limited observations, we could have noted that the issue of intra-and interobserver variations needs further attention, as we stated in the Discussion section. The r-values (Pearson correlation coefficients) found for the four participating physicians are indeed not very different, but are important as they reflect different levels of accuracy in the estimation of clinical jaundice compared to the serum total bilirubin (STB) measured in the lab. These differences may stem from experience and training, but may also reflect different levels of physiological sensitivity of the eye to colour, which definitely exist between different humans. The important point is that, in spite these differences, all could give relatively accurate estimations of clinical jaundice with acceptably good r-values.

As for the clinical experience of the four participating neonatologists, all were very well trained with 10-25 y of clinical experience in paediatrics in general, and neonatology specifically. As stated in the Discussion, in such a preliminary study we desired to check the best optimal settings for clinical estimation of jaundice, which also includes the most trained physicians. However, further studies are needed in order to consider the clinical ability of other health care providers to estimate clinical jaundice in newborns. Previous studies have shown encouraging results (1, 2), especially if training was provided. Our results should encourage us to further study this subject.

Our primary aim was by no means to look for an alternative to the use of hour-specific nomograms (3). This work of Bhutani et al. has provided us with valuable data on the predictive value of pre-discharge STB levels for subsequent clinically significant neonatal hyperbilirubinaemia. We also want to stress again the importance of other contributors to the clinical evaluation of jaundice, especially risk factors like SIB with significant neonatal jaundice, ABO incompatibility or glucose-6-phosphate dehydrogenase deficiency. What we have been trying to show was that clinical assessment of jaundice could substitute the initial step of Bhutani's approach. Instead of universal routine sampling of pre-discharge STB levels of all newborns, which is time and cost consuming, one could use clinical estimation of jaundice in all, and selective predischarge sampling of STB levels only in those who appear jaundiced. In a previous work (4), we have also shown that trained physicians had good ability to

In the eye of the beholder: how accurate is clinical estimation of jaundice in newborns?

Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns